Ledger.Open graph →
SEC Form D · filed August 17, 2018

Magnolia Neurosciences Corp

Offering
$13.1M
Sold
$8.0M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
NEW YORK, NY
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (18)

Benjamin I. Samaroo · Vancouver, British Columbia, CanadaDirectorTodd W. Kibler · Milwaukee, WIExecAdele Gorrilla · Philadelphia, PAExecJon D. Hammes · Milwaukee, WIDirectorSheona I. Docksteader · Vancouver, British Columbia, CanadaDirectorSteven I. Krause · Vancouver, British Columbia, CanadaExecAlfred Vericel · Paris, I0DirectorDean I. Sutton · Vancouver, British Columbia, CanadaExec · DirectorRoger Mills · Geneva, V8ExecMikhail Kalinichev · Geneva, V8Exec · DirectorJean-Philippe Rocher · Geneva, V8DirectorTimothy Dyer · Geneva, V8DirectorIsaac Manke · New York, NYExecVincent Lawton · Geneva, V8DirectorAri Qayumi · Menlo Park, CAExecJosephine B. Andonissamy · Luxembourg, LuxembourgDirectorBarbara J. Dalton · New York, NYDirectorJoel J. Marcus · Seattle, WADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗

Magnolia Neurosciences Corp — SEC Form D filing (2018) | Ledger